We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$6.85B
AUM Growth
-$481M
Cap. Flow
-$845M
Cap. Flow %
-12.34%
Top 10 Hldgs %
41.03%
Holding
120
New
33
Increased
27
Reduced
18
Closed
27

Top Buys

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$376M
2
AGN
Allergan plc
AGN
+$262M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$213M
4
HSP
HOSPIRA INC
HSP
+$179M
5
SIAL
SIGMA - ALDRICH CORP
SIAL
+$160M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$531M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$460M
3
SWY
SAFEWAY INC
SWY
+$318M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$258M
5
ROC
ROCKWOOD HLDGS INC
ROC
+$184M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.56%
2 Healthcare 10.46%
3 Industrials 10.4%
4 Technology 9.5%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTR
76
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$5.93M 0.09%
+2,002,000
New +$5.61M
LRMR icon
77
Larimar Therapeutics
LRMR
$434M
$5.15M 0.08%
10,833
+5,833
+117% +$2.77M
SFUN
78
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$3.63M 0.05%
+12,100
New +$4.03M
EJ
79
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$3.35M 0.05%
+617,500
New +$4.22M
MDRX
80
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.99M 0.04%
+250,000
New +$3.05M
ADVM
81
DELISTED
Adverum Biotechnologies
ADVM
$2.63M 0.04%
+6,500
New +$2.75M
ISSI
82
DELISTED
INTEGRATED SILICON SOLUTN INC
ISSI
$1.97M 0.03%
+110,000
New +$1.85M
ARUN
83
CALL
DELISTED
ARUBA NETWORKS, INC.
ARUN
$1.88M 0.03%
+76,700
New +$1.54M
RPRX
84
DELISTED
Repros Therapeutics Inc.
RPRX
$1.72M 0.03%
200,000
-100,000
-33% -$894K
ZSPH
85
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$1.05M 0.02%
+25,000
New +$1.14M
EVFM
86
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1.03M 0.02%
1,389
– –
EIGR
87
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$758K 0.01%
89
-355
-80% -$3.1M
AOI
88
DELISTED
Alliance One International
AOI
$639K 0.01%
+58,104
New +$652K
HELI
89
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$333K ﹤0.01%
8,333
– –
AMAT icon
90
CALL
Applied Materials
AMAT
$391B
– –
-1,685,000
Closed -$42M
ASH icon
91
Ashland
ASH
$3.33B
– –
-468,076
Closed -$27.4M
BHC icon
92
CALL
Bausch Health
BHC
$2.41B
– –
-650,000
Closed -$93M
BHC icon
93
Bausch Health
BHC
$2.41B
– –
-46,000
Closed -$6.58M
CTSH icon
94
Cognizant
CTSH
$27.9B
– –
-850,000
Closed -$44.8M
GIB icon
95
CGI
GIB
$15.5B
– –
-831,300
Closed -$31.7M
OI icon
96
O-I Glass
OI
$1.1B
– –
-4,145,000
Closed -$112M
TSLA icon
97
PUT
Tesla
TSLA
$1.43T
– –
-7,500,000
Closed -$111M
AGN
98
CALL
DELISTED
Allergan plc
AGN
– –
-216,000
Closed -$55.6M
AGN
99
PUT
DELISTED
Allergan plc
AGN
– –
-216,000
Closed -$55.6M
COVS
100
DELISTED
Covisint Corporation
COVS
– –
-307,818
Closed -$816K
1 2 3
4
5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2015 Portfolio in Review

As of Q1 2015, Thomas Steyer held 120 positions worth $6.85B, down 6.6% from $7.33B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Thomas Steyer withdrew a net $845M in Q1 2015, closing 27 positions and reducing 18 holdings. Its most notable exit was Allergan Inc, an estimated $531M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Thomas Steyer opened a new position in PHARMACYCLICS INC worth $498M.

  • Thomas Steyer's largest Q1 2015 buy was PHARMACYCLICS INC: 1,945,000 shares worth $498M.
  • Thomas Steyer added most to Allergan plc in Q1 2015, an estimated $262M increase.
  • Thomas Steyer's biggest Q1 2015 reduction was Coca-Cola Europacific Partners, cutting an estimated $123M.
  • Thomas Steyer fully exited Allergan Inc in Q1 2015, selling an estimated $531M.
  • Thomas Steyer's ten largest holdings make up 41% of its $6.85B portfolio in Q1 2015.
  • Thomas Steyer opened 33 new positions and closed 27 in Q1 2015.
  • Thomas Steyer's portfolio value fell 6.6% quarter-over-quarter to $6.85B.

Based on Farallon Capital Management's 13F filing for Q1 2015, filed 15 May 2015.